tiprankstipranks
Trending News
More News >
Affimed N.V. (DE:A28A)
:A28A
Germany Market
Advertisement

Affimed (A28A) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

A28A Financial Forecast

A28A Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

A28A Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:A28A
Wells Fargo
Wells Fargo
€9.35€0.08
Hold
-91.24%
Downside
Downgraded
05/14/25
Affimed's Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Cantor Fitzgerald Analyst forecast on DE:A28A
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
05/14/25
Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
Leerink Partners Analyst forecast on DE:A28A
Leerink Partners
Leerink Partners
€4.25€0.33
Hold
-65.83%
Downside
Downgraded
05/14/25
Affimed's Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:A28A
Wells Fargo
Wells Fargo
€9.35€0.08
Hold
-91.24%
Downside
Downgraded
05/14/25
Affimed's Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Cantor Fitzgerald Analyst forecast on DE:A28A
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgraded
05/14/25
Cantor Fitzgerald downgrades Affimed Therapeutics (AFMD) to NeutralCantor Fitzgerald analyst Li Watsek downgraded Affimed Therapeutics (NASDAQ: AFMD) from Overweight to Neutral.
Leerink Partners Analyst forecast on DE:A28A
Leerink Partners
Leerink Partners
€4.25€0.33
Hold
-65.83%
Downside
Downgraded
05/14/25
Affimed's Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Affimed

1 Month
xxx
Success Rate
2/5 ratings generated profit
40%
Average Return
-2.74%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -2.74% per trade.
3 Months
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
-19.08%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 20.00% of your transactions generating a profit, with an average return of -19.08% per trade.
1 Year
Yale JenLaidlaw
Success Rate
2/5 ratings generated profit
40%
Average Return
-9.10%
reiterated a buy rating a year ago
Copying Yale Jen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -9.10% per trade.
2 Years
xxx
Success Rate
1/5 ratings generated profit
20%
Average Return
-29.48%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -29.48% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

A28A Analyst Recommendation Trends

Rating
Sep 24
Nov 24
Dec 24
Jan 25
May 25
Strong Buy
6
5
9
9
7
Buy
9
9
5
2
1
Hold
3
10
16
18
15
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
24
30
29
23
In the current month, A28A has received 8 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. A28A average Analyst price target in the past 3 months is 0.21.
Each month's total comprises the sum of three months' worth of ratings.

A28A Stock Forecast FAQ

What is DE:A28A’s average 12-month price target, according to analysts?
Based on analyst ratings, Affimed N.V.’s 12-month average price target is 0.21.
    What is DE:A28A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:A28A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Affimed N.V. a Buy, Sell or Hold?
        Affimed N.V. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Affimed N.V.’s share price target?
          The average share price target for Affimed N.V. is 0.21. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €0.33 ,and the lowest forecast is €0.09. The average share price target represents -77.93% Decrease from the current price of €0.97.
            What do analysts say about Affimed N.V.?
            Affimed N.V.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Affimed N.V.?
              To buy shares of DE:A28A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis